Literature DB >> 26711497

Reduced GABAergic Action in the Autistic Brain.

Caroline E Robertson1, Eva-Maria Ratai2, Nancy Kanwisher3.   

Abstract

An imbalance between excitatory/inhibitory neurotransmission has been posited as a central characteristic of the neurobiology of autism [1], inspired in part by the striking prevalence of seizures among individuals with the disorder [2]. Evidence supporting this hypothesis has specifically implicated the signaling pathway of the inhibitory neurotransmitter, γ-aminobutyric acid (GABA), in this putative imbalance: GABA receptor genes have been associated with autism in linkage and copy number variation studies [3-7], fewer GABA receptor subunits have been observed in the post-mortem tissue of autistic individuals [8, 9], and GABAergic signaling is disrupted across heterogeneous mouse models of autism [10]. Yet, empirical evidence supporting this hypothesis in humans is lacking, leaving a gulf between animal and human studies of the condition. Here, we present a direct link between GABA signaling and autistic perceptual symptomatology. We first demonstrate a robust, replicated autistic deficit in binocular rivalry [11], a basic visual function that is thought to rely on the balance of excitation/inhibition in visual cortex [12-15]. Then, using magnetic resonance spectroscopy, we demonstrate a tight linkage between binocular rivalry dynamics in typical participants and both GABA and glutamate levels in the visual cortex. Finally, we show that the link between GABA and binocular rivalry dynamics is completely and specifically absent in autism. These results suggest a disruption in inhibitory signaling in the autistic brain and forge a translational path between animal and human models of the condition.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26711497     DOI: 10.1016/j.cub.2015.11.019

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  105 in total

1.  Binocular rivalry transitions predict inattention symptom severity in adult ADHD.

Authors:  Aiste Jusyte; Natalia Zaretskaya; Nina Maria Höhnle; Andreas Bartels; Michael Schönenberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-13       Impact factor: 5.270

Review 2.  Sensory perception in autism.

Authors:  Caroline E Robertson; Simon Baron-Cohen
Journal:  Nat Rev Neurosci       Date:  2017-09-29       Impact factor: 34.870

Review 3.  Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders.

Authors:  Jennifer H Foss-Feig; Brendan D Adkinson; Jie Lisa Ji; Genevieve Yang; Vinod H Srihari; James C McPartland; John H Krystal; John D Murray; Alan Anticevic
Journal:  Biol Psychiatry       Date:  2017-03-14       Impact factor: 13.382

4.  A Neural "Tuning Curve" for Multisensory Experience and Cognitive-Perceptual Schizotypy.

Authors:  Francesca Ferri; Yuliya S Nikolova; Mauro Gianni Perrucci; Marcello Costantini; Antonio Ferretti; Valentina Gatta; Zirui Huang; Richard A E Edden; Qiang Yue; Marco D'Aurora; Etienne Sibille; Liborio Stuppia; Gian Luca Romani; Georg Northoff
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

5.  Medial Frontal Lobe Neurochemistry in Autism Spectrum Disorder is Marked by Reduced N-Acetylaspartate and Unchanged Gamma-Aminobutyric Acid and Glutamate + Glutamine Levels.

Authors:  Andreia Carvalho Pereira; Inês R Violante; Susana Mouga; Guiomar Oliveira; Miguel Castelo-Branco
Journal:  J Autism Dev Disord       Date:  2018-05

6.  Altered hippocampal GABA and glutamate levels and uncoupling from functional connectivity in multiple sclerosis.

Authors:  Fei Gao; Xuntao Yin; Richard A E Edden; Alan C Evans; Junhai Xu; Guanmei Cao; Honghao Li; Muwei Li; Bin Zhao; Jian Wang; Guangbin Wang
Journal:  Hippocampus       Date:  2018-11       Impact factor: 3.899

Review 7.  Glycan susceptibility factors in autism spectrum disorders.

Authors:  Chrissa A Dwyer; Jeffrey D Esko
Journal:  Mol Aspects Med       Date:  2016-07-11

8.  Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial.

Authors:  Jeremy Veenstra-VanderWeele; Edwin H Cook; Bryan H King; Peter Zarevics; Maryann Cherubini; Karen Walton-Bowen; Mark F Bear; Paul P Wang; Randall L Carpenter
Journal:  Neuropsychopharmacology       Date:  2016-10-17       Impact factor: 7.853

Review 9.  Revisiting the excitation/inhibition imbalance hypothesis of ASD through a clinical lens.

Authors:  Russell G Port; Lindsay M Oberman; Timothy Pl Roberts
Journal:  Br J Radiol       Date:  2019-06-11       Impact factor: 3.039

10.  Concentrations of Cortical GABA and Glutamate in Young Adults With Autism Spectrum Disorder.

Authors:  Tamar Kolodny; Michael-Paul Schallmo; Jennifer Gerdts; Richard A E Edden; Raphael A Bernier; Scott O Murray
Journal:  Autism Res       Date:  2020-04-16       Impact factor: 5.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.